These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38724547)

  • 1. Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China.
    Liu J; Li C; Sun Y; Fu C; Wei S; Zhang X; Ma J; Zhao Q; Huo Y
    Sci Rep; 2024 May; 14(1):10620. PubMed ID: 38724547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of pretreatment drug resistance mutations in treatment-naïve people living with HIV-1 in Henan Province, China (2022/23).
    Liu J; Liu C; Wang Y; Wei S; Ma J; Li Y; Chen X; Zhao Q; Huo Y
    Infect Genet Evol; 2023 Nov; 115():105520. PubMed ID: 37898414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.
    Kao SW; Liu ZH; Wu TS; Ku SW; Tsai CL; Shie SS; Huang PY; Wu YM; Hsiao YH; Chen NY
    J Antimicrob Chemother; 2021 Feb; 76(3):722-728. PubMed ID: 33331635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016.
    Chen J; Liu Y; Liu S; Yuan D; Su L; Ye L; Gong F; Gao Y; Baloch S; Pei X
    Biomed Res Int; 2020; 2020():5894124. PubMed ID: 32280691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
    Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
    Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China.
    Liu M; He XQ; Deng RN; Tang SQ; Harypursat V; Lu YQ; He K; Huo Q; Yang HH; Liu Q; Chen YK
    HIV Med; 2022 Mar; 23 Suppl 1(Suppl 1):95-105. PubMed ID: 35293098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Subtype Diversity and Factors Affecting Drug Resistance among Patients with Virologic Failure in Antiretroviral Therapy in Hainan Province, China, 2014-2020.
    Yu E; Xu YJ; Li M; Yang Y; Liang HY; Zhong SM; Qin C; Lan YN; Li DW; Yu JP; Pang Y; Qin XQ; Liang H; Zhu KK; Ye L; Liang BY
    Biomed Environ Sci; 2023 Sep; 36(9):800-813. PubMed ID: 37803893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.
    Vardhanabhuti S; Taiwo B; Kuritzkes DR; Eron JJ; Bosch RJ
    Antivir Ther; 2015; 20(1):73-6. PubMed ID: 24699164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017-2021.
    Zhang M; Ma Y; Wang Z; Wang G; Wang Q; Li X; Lin F; Zhang C
    Virulence; 2024 Dec; 15(1):2373105. PubMed ID: 38934465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
    Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC
    BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study.
    Lao X; Zhang H; Deng M; Li Q; Xiao Q; He L; Ma L; Song A; Liang X; Yu F; Zhao H; Zhang F
    BMC Infect Dis; 2024 Jan; 24(1):8. PubMed ID: 38166689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal.
    Pimentel V; Pingarilho M; Sebastião CS; Miranda M; Gonçalves F; Cabanas J; Costa I; Diogo I; Fernandes S; Costa O; Corte-Real R; Martins MRO; Seabra SG; Abecasis AB; Gomes P
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017.
    Liang S; Liu Z; Wang S; Liu J; Shi L; Mao W; Liu C; Wan J; Zhu L; Huang M; Liu Y; Wang J; Ness P; Shan H; Zeng P; He M
    PLoS One; 2020; 15(12):e0243650. PubMed ID: 33347449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
    Bareng OT; Moyo S; Zahralban-Steele M; Maruapula D; Ditlhako T; Mokaleng B; Mokgethi P; Choga WT; Moraka NO; Pretorius-Holme M; Mine MO; Raizes E; Molebatsi K; Motswaledi MS; Gobe I; Mohammed T; Gaolathe T; Shapiro R; Mmalane M; Makhema JM; Lockman S; Essex M; Novitsky V; Gaseitsiwe S
    J Antimicrob Chemother; 2022 Apr; 77(5):1385-1395. PubMed ID: 35229102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China.
    Gao L; Xia H; Zeng R; Wu Y; Zaongo SD; Hu Y; Ma P
    HIV Med; 2022 Mar; 23 Suppl 1():84-94. PubMed ID: 35293099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.
    Álvarez H; Rava M; Martínez C; Portilla J; Peraire J; Rivero A; Cervero M; Mariño A; Poveda E; Llibre JM;
    HIV Med; 2022 Sep; 23(8):825-836. PubMed ID: 35234328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
    Xie YN; Zhu FX; Zhong YT; Chen YT; Gao Q; Lai XL; Liu JJ; Huang DD; Zhang YN; Chen X
    J Antimicrob Chemother; 2021 Oct; 76(11):2975-2982. PubMed ID: 34402512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.
    Fokam J; Mpouel Bala ML; Santoro MM; Takou D; Tala V; Beloumou G; Ngoufack ES; Chenwi C; Pabo Willy Leroi T; Njume D; Teto G; Dambaya B; Djupsa S; Sosso S; Ateba F; Kamta C; Bala L; Njom Nlend AE; Koki Ndombo P; Colizzi V; Perno CF; Ndjolo A
    HIV Med; 2022 Jul; 23(6):629-638. PubMed ID: 34951111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy.
    Hsu JY; Sun HY; Hsieh TW; Chang SY; Chuang YC; Huang YS; Hsiao CY; Su YC; Liu WC; Chang SF; Hung CC
    J Glob Antimicrob Resist; 2022 Jun; 29():7-16. PubMed ID: 35172201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Level Viremia among Adults Living with HIV on Dolutegravir-Based First-Line Antiretroviral Therapy Is a Predictor of Virological Failure in Botswana.
    Bareng OT; Moyo S; Mudanga M; Sebina K; Koofhethile CK; Choga WT; Moraka NO; Maruapula D; Gobe I; Motswaledi MS; Musonda R; Nkomo B; Ramaabya D; Chebani T; Makuruetsa P; Makhema J; Shapiro R; Lockman S; Gaseitsiwe S
    Viruses; 2024 May; 16(5):. PubMed ID: 38793602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.